| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3217 | Magreth-16a | Potent CB2 receptor inverse agonist |
|
| DCC3218 | Malonganenone A | Selective modulator of plasmodial Hsp70s with antimalarial activity |
|
| DCC3219 | Malp-2 Featured | Toll-like receptor 2/6 (TLR-2/6) agonist, regulating Lcn2 gene, promoting collateral growth |
|
| DCC3220 | Malp-2s | TLR2/6 agonist, activating the MyD88 pathway, provoking natural killer (NK) cell activation, increasing co-stimulators CD80/86 and CD40 |
|
| DCC3221 | Mal-rp | Novel quantitative chemical probe for live cell labeling and imaging of proteins that are sensitive to redox modifications |
|
| DCC3222 | Manassantin A | Natural anticancer, anti-inflammatory, neuroleptic agent, also having human acyl-CoA:cholesterol acyltransferase (ACAT) inhibitory activities |
|
| DCC3223 | Mao-b Inhibitor 58 | Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B). |
|
| DCC3224 | Mao-b Inhibitor C3 | Novel potent and highly selective MAO-B Inhibitor |
|
| DCC3225 | Mao-b Inhibitor C5 | Potent and selective MAO-B inhibitor |
|
| DCC3226 | Mao-b Inhibitor Cc1 | Novel potent selective and competitive inhibitor of MAO-B (IC 50 : 0.69 μM) |
|
| DCC3227 | Mao-b Inhibitor Cc2 | Novel potent and competitive inhibitor of MAO-B (IC 50 : 0.51 μM), also inhibiting BChE (IC 50 : 7.00 μM) |
|
| DCC3228 | Mao-b Ligand-1 | Novel selective MAO-B inhibitor |
|
| DCC3229 | Ma-pabc-adc-linker-18 | Novel stable antibody-drug conjugate (ADC) in mouse serum |
|
| DCC3230 | Maprotiline | Inhibitor of neuronal norepinephrine reuptake, reducing symptoms of anxiety associated with depression. |
|
| DCC3231 | Marbotinib | Novel highly efficient dual type I/II FMS-like tyrosine kinase inhibitor, disrupting the growth of leukemic cells |
|
| DCC3232 | Margatoxin | Inhibitor of voltage-gated K(+) (Kv) channels Kv1.3 and Kv1.5 |
|
| DCC3233 | Maritinone | Novel, active, and less toxic anti-tuberculosis (anti-TB) agent |
|
| DCC3234 | Maropitant Citrate [359875-09-5] Featured | Neurokinin receptor antagonist with antiemetic activity |
|
| DCC3235 | Massiliamide | Novel potent tyrosinase inhibitor from the Gram-negative bacterium Massilia albidiflava DSM 17472T |
|
| DCC3236 | May1-in-13a | Novel potent inhibitor of May1 with Ki = 12 ± 1 nM, also inhibiting wild-type HIV-1 protease with Ki = 32 ± 5 pM and three drug resistance-associated mutants with Ki values ranging from 24 to 320 pM |
|
| DCC3237 | Maysin | Natural Anti-inflammation Agent, Attenuating Amyloid Plaques by Inducing Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model |
|
| DCC3238 | Mb-001 | Novel potent inhibitor of the membrane-bound retinoid isomerase RPE65 |
|
| DCC3239 | Mb06322 | Prodrug of MB05032, acting as potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes |
|
| DCC3240 | Mb16695 | Novel Inhibitor of Mycobacterium tuberculosis α-1,4-Glucan Branching Enzyme (GlgB) |
|
| DCC3241 | Mb-211 | Novel inhibitor of dengue and West Nile virus NS2B-NS3 protease |
|
| DCC3242 | Mbls-in-5 | Novel non-hemolytic and low toxic inhibitor of metallo-β-lactamases (MBLs), restoring the activity of meropenem against Escherichia coli, Citrobacter freundii, Proteus mirabilis and Klebsiella pneumonia, which carried resistance genes of blaNDM-1 |
|
| DCC3243 | Mbp-c12 | Novel detergent, showing enhanced stability to all tested proteins compared to a gold standard detergent (DDM) |
|
| DCC3244 | Mbp-c9 | Novel detergent, showing enhanced stability to all tested proteins compared to a gold standard detergent (DDM) |
|
| DCC3245 | Mbri-001 | Deuterium-substituted anticancer agent, plinabulin, exhibiting better pharmacokinetic characteristics than that of plinabulin |
|
| DCC3246 | Mbt-fh Inhibitor-7 | The first selective small molecule inhibitor of the Mycobacterium tuberculosis fumarate hydratase |
|
